Bedel Financial Consulting Inc. purchased a new position in shares of Stryker Corporation (NYSE:SYK) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 1,916 shares of the medical technology company’s stock, valued at approximately $297,000.

Other institutional investors have also bought and sold shares of the company. Coldstream Capital Management Inc. grew its holdings in Stryker by 3.7% during the second quarter. Coldstream Capital Management Inc. now owns 17,445 shares of the medical technology company’s stock worth $2,421,000 after purchasing an additional 626 shares during the period. Retirement Systems of Alabama grew its holdings in Stryker by 2.5% during the third quarter. Retirement Systems of Alabama now owns 234,870 shares of the medical technology company’s stock worth $33,356,000 after purchasing an additional 5,656 shares during the period. Toronto Dominion Bank grew its holdings in Stryker by 25.8% during the second quarter. Toronto Dominion Bank now owns 105,403 shares of the medical technology company’s stock worth $14,625,000 after purchasing an additional 21,585 shares during the period. Colonial Trust Advisors grew its holdings in Stryker by 56.1% during the second quarter. Colonial Trust Advisors now owns 23,446 shares of the medical technology company’s stock worth $3,254,000 after purchasing an additional 8,426 shares during the period. Finally, Cornerstone Capital Management Holdings LLC. grew its holdings in Stryker by 3.1% during the third quarter. Cornerstone Capital Management Holdings LLC. now owns 55,255 shares of the medical technology company’s stock worth $7,847,000 after purchasing an additional 1,683 shares during the period. Institutional investors and hedge funds own 74.85% of the company’s stock.

In other news, Director Howard E. Cox, Jr. sold 7,400 shares of Stryker stock in a transaction that occurred on Friday, February 2nd. The shares were sold at an average price of $164.09, for a total value of $1,214,266.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, VP William E. Berry, Jr. sold 1,306 shares of Stryker stock in a transaction that occurred on Thursday, February 1st. The shares were sold at an average price of $164.42, for a total transaction of $214,732.52. The disclosure for this sale can be found here. Over the last quarter, insiders sold 16,840 shares of company stock valued at $2,749,989. 7.40% of the stock is owned by company insiders.

A number of equities analysts recently commented on the company. SunTrust Banks reiterated a “buy” rating and set a $179.00 price target (up previously from $161.00) on shares of Stryker in a report on Friday, January 26th. Cantor Fitzgerald restated a “hold” rating and set a $163.00 price objective on shares of Stryker in a research report on Tuesday, January 30th. Needham & Company LLC restated a “hold” rating on shares of Stryker in a research report on Wednesday, January 31st. Leerink Swann raised their price objective on shares of Stryker from $177.00 to $184.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 31st. Finally, Oppenheimer restated a “hold” rating and set a $165.00 price objective on shares of Stryker in a research report on Thursday, February 1st. Two analysts have rated the stock with a sell rating, nine have issued a hold rating and fourteen have assigned a buy rating to the company’s stock. Stryker has an average rating of “Hold” and a consensus target price of $162.50.

Shares of Stryker Corporation (NYSE:SYK) opened at $151.22 on Friday. The company has a debt-to-equity ratio of 0.66, a current ratio of 2.29 and a quick ratio of 1.59. Stryker Corporation has a 1 year low of $122.28 and a 1 year high of $170.00. The firm has a market cap of $56,590.00, a P/E ratio of 56.43, a PEG ratio of 2.21 and a beta of 0.70.

Stryker (NYSE:SYK) last released its quarterly earnings results on Tuesday, January 30th. The medical technology company reported $1.96 earnings per share for the quarter, beating analysts’ consensus estimates of $1.95 by $0.01. Stryker had a net margin of 8.20% and a return on equity of 24.55%. The company had revenue of $3.47 billion during the quarter, compared to the consensus estimate of $3.42 billion. During the same period in the previous year, the business earned $1.78 earnings per share. The firm’s quarterly revenue was up 9.9% on a year-over-year basis. analysts predict that Stryker Corporation will post 7.12 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Monday, April 30th. Stockholders of record on Thursday, March 29th will be given a $0.47 dividend. The ex-dividend date of this dividend is Wednesday, March 28th. This represents a $1.88 dividend on an annualized basis and a dividend yield of 1.24%. Stryker’s payout ratio is 70.15%.

WARNING: “Bedel Financial Consulting Inc. Invests $297,000 in Stryker Corporation (SYK) Stock” was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this article on another domain, it was illegally copied and republished in violation of international trademark & copyright law. The legal version of this article can be accessed at https://www.thecerbatgem.com/2018/02/10/bedel-financial-consulting-inc-invests-297000-in-stryker-corporation-syk-stock.html.

Stryker Profile

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK).

Institutional Ownership by Quarter for Stryker (NYSE:SYK)

Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.